Dengue fever in paediatric oncology patients undergoing chemotherapy: a retrospective study from a tertiary care center
- 1Department of Paediatric Oncology, Child Aid Association, National Institute of Child Health, Karachi, Pakistan
Abstract
Objective: To evaluate the clinical presentation, complications and outcomes of paediatric oncology patients undergoing chemotherapy with confirmed dengue fever.
Method: The retrospective study was conducted at the National Institute of Child Health, Karachi, and comprised data from October 1, 2022, to February 28, 2024, related to paediatric oncology patients aged 1-12 years with confirmed dengue fever and haematological or solid tumour malignancies who were on active treatment. Data from medical records was categorised as demographics, clinical presentation and complications. Data was analyzed using SPSS 26.
Results: Of the 11 patients with a median age of 5.5 years (range: 3-11 years) and an interquartile range (IQR) 4 years (IQR: 4-8), 6(54.5%) were boys and 5(46.5%) were girls. Acute lymphoblastic leukaemia was the most common malignancy 7(63.7%). Dengue fever was the diagnosis in 10(90.9%) patients, while 1(9.1%) had dengue haemorrhagic fever. Common symptoms included fever 11(100%) patients, vomiting 7(72.7%) and headache 6(54.5%). Thrombocytopenia was noted in 7(72.7%) patients, pleural effusion in 2(18.2%) and pneumonia in 3(27.3%). All 11(100%) patients were treated successfully with no fatalities.
Conclusion: Early diagnosis and supportive care led to favourable outcomes even though distinguishing dengue from febrile neutropenia remains clinically challenging due to overlapping features.
Key Words: Dengue, Paediatric oncology, Chemotherapy, Retrospective studies, Febrile neutropenia, Haematological neoplasms, Pakistan.
Related
- Pretreatment Body Composition and Its Association with Pathologic Complete Response and Survival in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Retrospective Cohort Study
- Contrast-Associated Acute Kidney Injury in Oncology Patients During Active Chemotherapy: A Saudi Arabian Retrospective Study.
- Profile of Invasive Fungal Infections in a Paediatric Haemato-Oncology Unit: A Five-Year Retrospective Cohort Study From a Tertiary Care Centre in South India
- Reducing surgical site infections among paediatric patients undergoing cardiac surgery: a multi-disciplinary quality improvement initiative
- Fear of progression as a mediator between symptom burden and social alienation in lung cancer patients undergoing chemotherapy
BibTeX
@article{aijaz2026dengue,
title = {{Dengue fever in paediatric oncology patients undergoing chemotherapy: a retrospective study from a tertiary care center}},
author = {Wajiha Aijaz and Ammara Hameed and Ayza Farooq and Syed Habib Ahmed and Uzma Imam},
journal = {Journal of the Pakistan Medical Association},
year = {2026},
month = nov,
doi = {10.47391/jpma.30270},
url = {https://doi.org/10.47391/jpma.30270},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dengue fever in paediatric oncology patients undergoing chemotherapy: a retrospective study from a tertiary care center
AU - Wajiha Aijaz
AU - Ammara Hameed
AU - Ayza Farooq
AU - Syed Habib Ahmed
AU - Uzma Imam
PY - 2026
DA - 2026/11/01
JO - Journal of the Pakistan Medical Association
DO - 10.47391/jpma.30270
UR - https://doi.org/10.47391/jpma.30270
AB - Objective: To evaluate the clinical presentation, complications and outcomes of paediatric oncology patients undergoing chemotherapy with confirmed dengue fever. Method: The retrospective study was conducted at the National Institute of Child Health, Karachi, and comprised data from October 1, 2022, to February 28, 2024, related to paediatric oncology patients aged 1-12 years with confirmed dengue fever and haematological or solid tumour malignancies who were on active treatment. Data from medical records was categorised as demographics, clinical presentation and complications. Data was analyzed using SPSS 26. Results: Of the 11 patients with a median age of 5.5 years (range: 3-11 years) and an interquartile range (IQR) 4 years (IQR: 4-8), 6(54.5%) were boys and 5(46.5%) were girls. Acute lymphoblastic leukaemia was the most common malignancy 7(63.7%). Dengue fever was the diagnosis in 10(90.9%) patients, while 1(9.1%) had dengue haemorrhagic fever. Common symptoms included fever 11(100%) patients, vomiting 7(72.7%) and headache 6(54.5%). Thrombocytopenia was noted in 7(72.7%) patients, pleural effusion in 2(18.2%) and pneumonia in 3(27.3%). All 11(100%) patients were treated successfully with no fatalities. Conclusion: Early diagnosis and supportive care led to favourable outcomes even though distinguishing dengue from febrile neutropenia remains clinically challenging due to overlapping features. Key Words: Dengue, Paediatric oncology, Chemotherapy, Retrospective studies, Febrile neutropenia, Haematological neoplasms, Pakistan.
SN - 0030-9982
ER -